In pancreatic ductal adenocarcinoma (PDAC), SERPINB5 appears to function as an oncogene, and unmethylated SERPINB5 has been identified as a specific marker for PDAC in clinical samples, suggesting its potential utility for liquid biopsies [45]. Here, SERPINB5 is linked to pancreatic ductal adenocarcinoma.